Circulating tumour DNA as biomarker for rectal cancer: A systematic review and meta-analyses

Circulating tumour DNA as biomarker for rectal cancer: A systematic review and meta-analyses

BackgroundCirculating tumour DNA (ctDNA) has been established as a promising (prognostic) biomarker with the potential to personalise treatment in cancer patients. The objective of this systematic review is to provide an overview of the current literature and the future perspectives of ctDNA in non-...

Full description

Bibliographic Details
Main Authors: Jan M. van Rees, Lissa Wullaert, Alexander A. J. Grüter, Yassmina Derraze, Pieter J. Tanis, Henk M. W. Verheul, John W. M. Martens, Saskia M. Wilting, Geraldine Vink, Jeroen L. A. van Vugt, Nick Beije, Cornelis Verhoef
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Oncology
Subjects:
Ctdna (circulating tumour DNA)
cfDNA (circulating free DNA)
rectal cancer
minimal residual disease (MRD)
liquid biopsy
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1083285/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1083285/full

Similar Items